---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-011160"
form_type: "8-K"
ticker: "QCLS"
cik: "0001321834"
company_name: "Q/C TECHNOLOGIES, INC."
filed_at: "2025-03-21T23:59:59+00:00"
generated_at: "2026-05-24T08:35:51.165600+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# TNF Pharma receives Nasdaq bid price deficiency notice; 180 days to cure

## Summary
- Received Nasdaq letter on March 17, 2025 for failure to maintain minimum $1.00 bid price over 30 consecutive business days.
- Compliance period of 180 calendar days until September 15, 2025; must have $1.00 closing bid for 10 consecutive days.
- If not cured, may get additional 180 days by meeting other listing standards and providing intent to cure, e.g., reverse stock split.

## SEC filing metadata
- accession: 0001493152-25-011160
- form_type: 8-K
- ticker: QCLS
- cik: 0001321834
- company_name: Q/C TECHNOLOGIES, INC.
- filed_at: 2025-03-21T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1321834/000149315225011160/0001493152-25-011160-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1321834/000149315225011160/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-011160
- JSON: https://secwatch.observer/filing/0001493152-25-011160.json
- Plain text: https://secwatch.observer/filing/0001493152-25-011160.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.